Liver cirrhosis is currently one of the leading causes of death in most countries, and responsible for a great use of health resources. The European project LIVERHOPE, led by Pere Ginés, professor of Medicine and head of the Hepatology Service of the Clinic Hospital and member of IDIBAPS, coordinator center of the project, aims to research on a treatment to stop the progress of the disease, based on the repurposing of already existing drugs that are used in other indications. The treatment consists on the combination of two drugs, simvastatin and rifaximin. In order to test it, there will be two clinical trials. The project is financially supported by the H2020 program with 6M euros and will be carried out between 2017 and 2021.

Further information

Image: Participants of the first meeting for the project LiverHope in Barcelona. Photo: IDIBAPS

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Identifican potenciales biomarcadores te...

by CIBERDEM - Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas

Se han presentado los nuevos biomarcadores identificados a partir de l...

Photos Stream